This course has expired. View available courses.
Gastroenterology
Making the Switch: Biosimilar Infliximab in the Treatment of Inflammatory Bowel Disease – Certificate of Completion
The advent of novel biologic medicines for the treatment of inflammatory bowel disease (IBD) has increased the availability of therapeutic options to induce and maintain remission in patients with this disease. They have become an important modality of treatment in IBD and the mainstay of therapy in patients with fistulising or perianal Crohn’s disease (CD).
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2020-01-06
The advent of novel biologic medicines for the treatment of inflammatory bowel disease (IBD) has increased the availability of therapeutic options to induce and maintain remission in patients with this disease. They have become an important modality of treatment in IBD and the mainstay of therapy in patients with fistulising or perianal Crohn’s disease (CD).
Faculty
Lena Thin
MBBS, FRACP, MClinRes,
Harry Perkins Institute of Medical Research,
Western Australia Department of Health,
Fiona Stanley Hospital,
Perth, Western Australia
Miles Sparrow
Associate Professor
MBBS, PhD, FRACP
Director, Inflammatory Bowel Disease Unit
The Alfred Hospital, Melbourne, VIC
Monash University, Melbourne, VIC
Learning objectives
Après avoir complété ce programme, le participant sera en mesure de :
- Expliquer l’importance particulière de l’immunisation contre la grippe chez les enfants âgés de 6 mois à 2 ans
- Offrir de manière efficace et efficiente l’immunisation contre la grippe aux parents d’enfants âgés de 6 mois à 2 ans
- Adresser les hésitations des parents au sujet de la vaccination et minimiser la douleur lors de l’immunisation contre la grippe
- Fournir l’immunisation contre la grippe à cette population selon les lignes directrices canadiennes
Accreditation
# of credits: 1 
Duration: 1 hr FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
